Vaisali Balasubramaniam & P K Krishnan Namboori. (2021). Development of Hif1α pharmacogenomic mutation models to study individual variations in drug action for tumor hypoxia: An in silico approach. Wolters Kluwer Medknow Publications.
Chicago Style (17th ed.) CitationVaisali Balasubramaniam and P K Krishnan Namboori. Development of Hif1α Pharmacogenomic Mutation Models to Study Individual Variations in Drug Action for Tumor Hypoxia: An in Silico Approach. Wolters Kluwer Medknow Publications, 2021.
MLA (9th ed.) CitationVaisali Balasubramaniam and P K Krishnan Namboori. Development of Hif1α Pharmacogenomic Mutation Models to Study Individual Variations in Drug Action for Tumor Hypoxia: An in Silico Approach. Wolters Kluwer Medknow Publications, 2021.
Warning: These citations may not always be 100% accurate.